High concentrations of dexamethasone suppress the proliferation but not the differentiation or further maturation of human osteoblast precursors in vitro: relevance to glucocorticoid-induced osteoporosis.
about
Gene expression analysis in human osteoblasts exposed to dexamethasone identifies altered developmental pathways as putative drivers of osteoporosis.High-throughput screening of a small molecule library for promoters and inhibitors of mesenchymal stem cell osteogenic differentiation.Mitogen-activated protein kinase phosphatase 1/dual specificity phosphatase 1 mediates glucocorticoid inhibition of osteoblast proliferationOsteogenic differentiation of human mesenchymal stem cells synergistically enhanced by biomimetic peptide amphiphiles combined with conditioned medium.Prostacyclin suppresses twist expression in the presence of indomethacin in bone marrow-derived mesenchymal stromal cells.β2-Adrenergic receptor signaling in osteoblasts contributes to the catabolic effect of glucocorticoids on bone.Glucocorticoid induced osteoblast apoptosis by increasing E4BP4 expression via up-regulation of Bim.Dexamethasone in osteogenic medium strongly induces adipocyte differentiation of mouse bone marrow stromal cells and increases osteoblast differentiation.Human mesenchymal stem cells in contact with their environment: surface characteristics and the integrin system.The Role of MKP-1 in the Anti-Proliferative Effects of Glucocorticoids in Primary Rat Pre-OsteoblastsEffects of glucocorticoid receptor small interfering RNA delivered using poly lactic-co-glycolic acid microparticles on proliferation and differentiation capabilities of human mesenchymal stromal cells.Cell-mediated delivery of glucocorticoids from thiol-ene hydrogelsThe effects of dexamethasone on human patellar tendon stem cells: implications for dexamethasone treatment of tendon injury.The effect of laminin-1-doped nanoroughened implant surfaces: gene expression and morphological evaluation.High glucose inhibits osteogenic differentiation through the BMP signaling pathway in bone mesenchymal stem cells in miceReceptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease.Mesenchymal progenitors in osteopenias of diverse pathologies: differential characteristics in the common shift from osteoblastogenesis to adipogenesisGlucocorticoid receptor and Histone deacetylase 6 mediate the differential effect of dexamethasone during osteogenesis of mesenchymal stromal cells (MSCs).A cell rolling cytometer reveals the correlation between mesenchymal stem cell dynamic adhesion and differentiation state.Marrow adipocytes inhibit the differentiation of mesenchymal stem cells into osteoblasts via suppressing BMP-signaling.Osteogenic effects of D+beta-3,4-dihydroxyphenyl lactic acid (salvianic acid A, SAA) on osteoblasts and bone marrow stromal cells of intact and prednisone-treated rats.Methotrexate toxicity in growing long bones of young rats: a model for studying cancer chemotherapy-induced bone growth defects in children.Effects of dexamethasone, ascorbic acid and β-glycerophosphate on the osteogenic differentiation of stem cells in vitroPerfusion bioreactor studies of chondrocyte growth in alginate-chitosan capsules.Effects of PEMF and glucocorticoids on proliferation and differentiation of osteoblasts.Dexamethasone and basic-fibroblast growth factor regulate markers of mineralization in cementoblasts in vitro.AT-RvD1 combined with DEX is highly effective in treating TNF-α-mediated disruption of the salivary gland epitheliumThe effect of newer anti-rheumatic drugs on osteogenic cell proliferation: an in-vitro study.A novel role for the mineralocorticoid receptor in glucocorticoid driven vascular calcification.Immobilized WNT Proteins Act as a Stem Cell Niche for Tissue Engineering.Mesenchymal stem cells as a potent cell source for bone regeneration.Phenotypic effects of continuous or discontinuous treatment with dexamethasone and/or calcitriol on osteoblasts differentiated from rat bone marrow stromal cells.Drug delivery from hydroxyapatite-coated titanium surfaces using biodegradable particle carriers.Immunocytochemical evidence on the effects of glucocorticoids on type I collagen synthesis in human osteoblastic cells.Bone morphogenetic proteins 4 and 2/7 induce osteogenic differentiation of mouse skin derived fibroblast and dermal papilla cells.Osteogenic Programming of Human Mesenchymal Stem Cells with Highly Efficient Intracellular Delivery of RUNX2.Extracts from Plastrum testudinis promote proliferation of rat bone-marrow-derived mesenchymal stem cells.4-Phenyl butyric acid prevents glucocorticoid-induced osteoblast apoptosis by attenuating endoplasmic reticulum stress.Isolation, culture and induced differentiation of rabbit mesenchymal stem cells into osteoblasts.Human mesenchymal stromal cells response to biomimetic octacalcium phosphate containing strontium.
P2860
Q33273462-1C3F53DD-DE9E-4195-B5CB-0D7CC4DF13F3Q33687471-1611028D-E429-44A4-8CB8-867D04372086Q33725761-5AFAA491-F643-4715-AF69-A2159F494568Q34393581-E4B15DCF-C008-4C6A-BA2A-F3C3B84058C9Q34548370-AF26A2B9-A37D-4E44-8E72-4F557A71C020Q34696971-3D94082A-B191-4AB7-9C2D-12F896F4BEC0Q35128376-BE8A4CDF-509F-4DB6-9A91-83DAFF25A66FQ35176666-DDEE2875-D60D-4430-A012-CF775EB53F79Q35458958-0D593F27-34CB-47F9-871E-46C3543674B4Q35742651-CA6E2393-EFEE-4DAA-86E3-16F7D09DFF91Q35855686-8ACAEB30-9436-43B8-A17E-3BE710C2378AQ36366479-25E8ACCA-FA17-4704-AAF0-5D773527D1E3Q36400236-905B0308-5B66-4155-9438-098C87CFC89CQ36490408-0F7AF44A-2ECC-4DC4-8511-5136CBA59925Q36806811-6FB7340E-6B47-4A0D-99C4-8AB4462BFFB2Q36860987-4DB0CF53-7A29-4094-9985-49029E79C334Q37117479-5A971817-D094-4927-829A-A10A7ECCBBC8Q37453914-3AB01AAB-4757-499E-B80F-BF6531E6732BQ37457516-329961D0-5033-4465-8665-7A5CF250A840Q37630840-A4236AD3-EF05-4B47-AB2D-82AD01BAA6AEQ37728138-500727AF-3A89-40B5-9DAA-CE715D0CFAE9Q37871863-F19FEF92-05BE-4334-9131-DDFBDC94A892Q38145324-2C74D71E-7AF3-4EA4-B96E-DFFCAA9D91CFQ39166321-C57FC680-1AB7-48C0-BAAE-72E07559B713Q39335422-3ECF15A7-E4D9-44C9-972B-91F7A73A945FQ40371580-20D14158-B671-49C9-8BC1-B9C60C3E3BA3Q41460908-E31651D7-80C8-4F05-AF13-75E13CCF6EE2Q41579402-A986503A-6F5A-4D86-ADD4-A6A6EC596186Q42046693-E668A4E4-F001-425D-948B-19FE54A3458FQ42421187-3B9EB403-11F8-463D-BB2E-B274EF6435B5Q42625406-E07C86FA-AE52-4BFF-9758-4C3DB98D16C6Q43968101-7BC37B40-F0D0-4A18-A384-B4B76CD00019Q44416238-F7E94347-247B-427B-933F-FE0D42A32C07Q44635686-9ED912E5-F741-4BCC-8965-C27D77C467F2Q45410271-E6878370-C519-409B-9023-DF9E50A2BA6CQ45873834-3E627ED7-59EE-4899-84FF-DDBD93EBEF62Q47790552-C33A45AB-ACD8-410F-86F1-95D99DEAF1FFQ51454891-CCABB808-B86F-490F-916E-C9979C54CB51Q52340932-44E914A7-FE07-4A5E-AB74-607F3D3B9F01Q53137926-72338F2D-CB48-44DE-8F8B-9F2AA9ED586E
P2860
High concentrations of dexamethasone suppress the proliferation but not the differentiation or further maturation of human osteoblast precursors in vitro: relevance to glucocorticoid-induced osteoporosis.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
High concentrations of dexamet ...... orticoid-induced osteoporosis.
@ast
High concentrations of dexamet ...... orticoid-induced osteoporosis.
@en
type
label
High concentrations of dexamet ...... orticoid-induced osteoporosis.
@ast
High concentrations of dexamet ...... orticoid-induced osteoporosis.
@en
prefLabel
High concentrations of dexamet ...... orticoid-induced osteoporosis.
@ast
High concentrations of dexamet ...... orticoid-induced osteoporosis.
@en
P2093
P921
P356
P1433
P1476
High concentrations of dexamet ...... orticoid-induced osteoporosis.
@en
P2093
P356
10.1093/RHEUMATOLOGY/40.1.74
P577
2001-01-01T00:00:00Z